Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:59 |
|---|---|
| Enthalten in: |
Clinical chemistry and laboratory medicine - 59(2021), 5 vom: 27. Apr., Seite e179-e183 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Favresse, Julien [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Viral |
|---|
| Anmerkungen: |
Date Completed 29.04.2021 Date Revised 22.08.2021 published: Electronic-Print Citation Status MEDLINE |
|---|
| doi: |
10.1515/cclm-2020-1736 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM321151062 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM321151062 | ||
| 003 | DE-627 | ||
| 005 | 20231225175212.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1515/cclm-2020-1736 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1070.xml |
| 035 | |a (DE-627)NLM321151062 | ||
| 035 | |a (NLM)33554588 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Favresse, Julien |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.04.2021 | ||
| 500 | |a Date Revised 22.08.2021 | ||
| 500 | |a published: Electronic-Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a antibody | |
| 650 | 4 | |a kinetics | |
| 650 | 4 | |a long-term | |
| 650 | 7 | |a Antibodies, Viral |2 NLM | |
| 700 | 1 | |a Elsen, Marc |e verfasserin |4 aut | |
| 700 | 1 | |a Eucher, Christine |e verfasserin |4 aut | |
| 700 | 1 | |a Laffineur, Kim |e verfasserin |4 aut | |
| 700 | 1 | |a Van Eeckhoudt, Sandrine |e verfasserin |4 aut | |
| 700 | 1 | |a Nicolas, Jean-Baptiste |e verfasserin |4 aut | |
| 700 | 1 | |a Gillot, Constant |e verfasserin |4 aut | |
| 700 | 1 | |a Dogné, Jean-Michel |e verfasserin |4 aut | |
| 700 | 1 | |a Douxfils, Jonathan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical chemistry and laboratory medicine |d 1998 |g 59(2021), 5 vom: 27. Apr., Seite e179-e183 |w (DE-627)NLM095304118 |x 1437-4331 |7 nnns |
| 773 | 1 | 8 | |g volume:59 |g year:2021 |g number:5 |g day:27 |g month:04 |g pages:e179-e183 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1515/cclm-2020-1736 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 59 |j 2021 |e 5 |b 27 |c 04 |h e179-e183 | ||